References of "Daly, Adrian"
     in
Bookmark and Share    
Full Text
See detailSeguimiento prospectivo ecocardiografico de 104 pacientes con enffermedades endocrinologicas tratados con cabergolina
Daly, Adrian ULg; VROONEN, Laurent ULg; Lancellotti, Patrizio ULg et al

in Abstract book - 54 Congreso Sociedad Espanola de Endocrinologia y nutrition (2012, May 23)

Detailed reference viewed: 13 (1 ULg)
Full Text
See detailCaracteristicas de prolactinomas resisitentes a dosis estandar de cabergolina : un estudio multicentrico en 92 pacientes
Beckers, Albert ULg; Jaffrain-Réa, ML; VROONEN, Laurent ULg et al

in Abstract book - 54 Congreso Sociedad Espanola de Endocrinologia y nutrition (2012, May 23)

Detailed reference viewed: 14 (0 ULg)
Full Text
See detailEl sindrome tiro-gastrico : screening en 410 pacientes atendidos pro patologia tiroidea
Tome, M; VALDES SOCIN, Hernan Gonzalo ULg; Auriemma, R et al

in Abstract book - 54 Congreso Sociedad Espanola de Endocrinologia y nutrition (2012, May 23)

Detailed reference viewed: 18 (0 ULg)
Full Text
See detailA prospective study of cardiac valvular status in patients treated with cabergoline for Endocrine Disease
VROONEN, Laurent ULg; LANCELLOTTI, Patrizio ULg; TOME, M et al

in Endocrine abstracts - May 2012, volume 29 (2012, May)

Detailed reference viewed: 18 (5 ULg)
Full Text
See detailAry Hydrocarbon receptor interacting protein (AIP) on somatotroph adenomas : a molecular target for somatostatin analogues ?
JAFFRAIN-REA, M; ANGELINI, M; OCCHI, G et al

in Endocrine abstracts - May 2012, volume 29 (2012, May)

Detailed reference viewed: 24 (1 ULg)
Full Text
Peer Reviewed
See detailClinical characterization of cabergoline resistant prolactinomas : a multicenter experience on 92 patients
VROONEN, Laurent ULg; Jaffrain Rea, ML; PETROSSIANS, Patrick ULg et al

in Annales d'Endocrinologie (2012, April), 73(2), 153

Detailed reference viewed: 29 (5 ULg)
Full Text
Peer Reviewed
See detailA prospective study of cardiac valvular status in patients treated with cabergoline for Endocrine Disease
VROONEN, Laurent ULg; Lancellotti, Patrizio ULg; Tome Garcia, M et al

in Annales d'Endocrinologie (2012, April), 73(2), 148

Detailed reference viewed: 23 (4 ULg)
Full Text
Peer Reviewed
See detailCyclin dependent kinase inhibitor (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenomas (FIPA) kindreds
Tichomirowa, M.; Lee, M.; Barlier, A. et al

in Endocrine-Related Cancer (2012), 19

Detailed reference viewed: 12 (5 ULg)
Full Text
See detailThe clinical and genetic characteristics of patients with gigantism
Rostomyan, Liliya ULg; Daly, Adrian ULg; Tichomirowa, M et al

in Abstract book - Aspiring excellence : Pituitary expert forum (2012)

Detailed reference viewed: 16 (2 ULg)
Full Text
Peer Reviewed
See detailOverview of genetic testing in patients with pituitary adenomas
Beckers, Albert ULg; Rostomyan, Liliya ULg; Daly, Adrian ULg

in Annales d'Endocrinologie (2012), 73

Detailed reference viewed: 18 (5 ULg)
Full Text
Peer Reviewed
See detailThe Liege Acromegaly Survey (LAS) : A new software tool for the study of acromegaly
PETROSSIANS, Patrick ULg; Tichomirowa, M; Stevenaert, Achille ULg et al

in Annales d'Endocrinologie (2012), 73

Detailed reference viewed: 35 (8 ULg)
See detailFamilial Pituitary Adenomas
Auriemma, RS; Vasilev, V; Daly, Adrian ULg et al

in Endocrinologia Clinica (2012)

Detailed reference viewed: 15 (4 ULg)
Full Text
Peer Reviewed
See detailProlactinomas Resistant to Standard Doses of Cabergoline : A multicenter study of 92 patients
VROONEN, Laurent ULg; Jaffrain-Rea, ML; PETROSSIANS, Patrick ULg et al

in European Journal of Endocrinology (2012), 167

Detailed reference viewed: 43 (10 ULg)
Full Text
See detailClinical characterization of cabergoline resistant prolactinomas : a multicenter experience on 92 patients
VROONEN, Laurent ULg; Jaffrain-Rea, M. L.; PETROSSIANS, Patrick ULg et al

in ENEA Munich - abstract book (2011, December)

Detailed reference viewed: 21 (4 ULg)
Full Text
See detailGenetic screening for AIP mutations in Young patients with sporadic and Familial Pituitary Macroadenomas
Yaneva, M.; Elenkova, A.; Daly, Adrian ULg et al

in Endocrinologia = Endokrinologiia (2011), 16(1), 41-48

Detailed reference viewed: 27 (12 ULg)
Full Text
Peer Reviewed
See detailGenetic causes of familial pituitary adenomas
Vandeva, Silvia; Zacharieva, S.; Daly, Adrian ULg et al

in Growth Hormone Related Diseases and Therapy - Contemporary Endocrinology (2011)

Detailed reference viewed: 21 (9 ULg)
Full Text
Peer Reviewed
See detailHigh prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
Tichomirowa, Maria A; Barlier, Anne; Daly, Adrian ULg et al

in European Journal of Endocrinology (2011), 165(4), 509-15

BACKGROUND: Aryl hydrocarbon receptor interacting protein (AIP) mutations (AIPmut) cause aggressive pituitary adenomas in young patients, usually in the setting of familial isolated pituitary adenomas ... [more ▼]

BACKGROUND: Aryl hydrocarbon receptor interacting protein (AIP) mutations (AIPmut) cause aggressive pituitary adenomas in young patients, usually in the setting of familial isolated pituitary adenomas. The prevalence of AIPmut among sporadic pituitary adenoma patients appears to be low; studies have not addressed prevalence in the most clinically relevant population. Hence, we undertook an international, multicenter, prospective genetic, and clinical analysis at 21 tertiary referral endocrine departments. METHODS: We included 163 sporadic pituitary macroadenoma patients irrespective of clinical phenotype diagnosed at <30 years of age. RESULTS: Overall, 19/163 (11.7%) patients had germline AIPmut; a further nine patients had sequence changes of uncertain significance or polymorphisms. AIPmut were identified in 8/39 (20.5%) pediatric patients. Ten AIPmut were identified in 11/83 (13.3%) sporadic somatotropinoma patients, in 7/61 (11.5%) prolactinoma patients, and in 1/16 non-functioning pituitary adenoma patients. Large genetic deletions were not seen using multiplex ligation-dependent probe amplification. Familial screening was possible in the relatives of seven patients with AIPmut and carriers were found in six of the seven families. In total, pituitary adenomas were diagnosed in 2/21 AIPmut-screened carriers; both had asymptomatic microadenomas. CONCLUSION: Germline AIPmut occur in 11.7% of patients <30 years with sporadic pituitary macroadenomas and in 20.5% of pediatric patients. AIPmut mutation testing in this population should be considered in order to optimize clinical genetic investigation and management. [less ▲]

Detailed reference viewed: 38 (11 ULg)
Full Text
Peer Reviewed
See detailUne nouvelle forme d'adénomes hypophysaires familiaux : les FIPA-Détection et prise en charge
Beckers, Albert ULg; PETROSSIANS, Patrick ULg; Auriemma, R. S. et al

in Correspondances en MHDN (2011)

Detailed reference viewed: 36 (8 ULg)
Full Text
Peer Reviewed
See detailResistant prolactinomas
Vasilev, V.; Daly, Adrian ULg; VROONEN, Laurent ULg et al

in Journal of Endocrinological Investigation (2011), 34

Detailed reference viewed: 20 (11 ULg)
Full Text
Peer Reviewed
See detailHyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa, C.; Lagonigro, M. S.; Magri, F. et al

in Endocrine-Related Cancer (2011)

Mutations of the aryl hydrocarbon receptor interacting protein (AIP) gene are associated with pituitary adenomas that usually occur as familial isolated pituitary adenomas (FIPA). Detailed pathological ... [more ▼]

Mutations of the aryl hydrocarbon receptor interacting protein (AIP) gene are associated with pituitary adenomas that usually occur as familial isolated pituitary adenomas (FIPA). Detailed pathological and tumor genetic data on AIP mutation-related pituitary adenomas are scarce. Non-identical twin females presented as adolescents to the emergency department with severe progressive headaches caused by large pituitary macroadenomas requiring emergency neurosurgery; one patient had incipient pituitary apoplexy. Post-surgically the patients were found to have silent somatotrope adenomas on pathological examination. Furthermore, the light microscopic, immunohistochemical and electron microscopic studies demonstrated tumors of virtually identical characteristics. The adenomas were accompanied by multiple areas of pituitary hyperplasia, which stained positively for growth hormone, indicating somatotrope hyperplasia. Genetic analyses of the FIPA kindred revealed a novel E216X mutation of the AIP gene, which was present in both affected patients and the unaffected father. Molecular analysis of surgical specimens revealed loss of heterozygosity (LOH) in the adenoma, but showed that LOH was not present in the hyperplasic pituitary tissue from either patient. AIP immunostaining confirmed normal staining in the hyperplastic tissue and decreased staining in the adenoma in the tumors from both patients. These results demonstrate that patients with AIP germline mutation can present with clinically silent somatotroph pituitary adenomas. The finding of somatotrope hyperplasia unaccompanied by AIP LOH, suggests that LOH at the AIP locus may be a late event in the progression from hyperplastic to adenomatous tissue. [less ▲]

Detailed reference viewed: 27 (6 ULg)